MiR-21 is a miRNA overexpressed in many types of cancer, particularly breast cancer, and acts as an oncogenic marker by targeting many suppressor genes such as targeting programmed cell death 4 (PDCD4), metalloproteinase inhibitor 3 (TIMP3), PTEN, and Bcl-2 [38,39]. This evidence concerns the gene PTEN and breast carcinoma.